About 3 Trademarks found for “BIOCRYST PHARMACEUTICALS, INC.”

Pharmaceuticals for the treatment of autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; anti-viral pharmaceuticals; anti-inflammatory pharmaceuticals; pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphomas

Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; development of pharmaceuticals for the treatment of development of obesity; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of transplant rejection; development of pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphoma

Pharmaceuticals for the treatment of autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; anti-viral pharmaceuticals; anti-inflammatory pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas.

Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; development of pharmaceuticals for the treatment of development of obesity; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of transplant rejection; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma.

Pharmaceuticals for the treatment of autoimmune, cancer and cardiovascular diseases and disorders; pharmaceuticals for the treatment of viral diseases and disorders, namely, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), SARS and West Nile virus; pharmaceuticals for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases.

Medical and scientific research for others, namely, the discovery and development of pharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer and cardiovascular disease and disorders.